A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
Clinical trial NCT02035553 · COMPLETED
Trial details
- NCT number
- NCT02035553
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-09-28
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.